PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.6631
+0.0209 (3.25%)
At close: Jun 10, 2025, 4:00 PM
0.6800
+0.0169 (2.55%)
After-hours: Jun 10, 2025, 7:57 PM EDT
PAVmed Revenue
PAVmed had revenue of $8.00K in the quarter ending March 31, 2025, a decrease of -99.21%. This brings the company's revenue in the last twelve months to $1.99M, down -33.92% year-over-year. In the year 2024, PAVmed had annual revenue of $3.00M with 22.15% growth.
Revenue (ttm)
$1.99M
Revenue Growth
-33.92%
P/S Ratio
3.65
Revenue / Employee
$51,103
Employees
39
Market Cap
11.68M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
PAVM News
- 7 days ago - PAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute - PRNewsWire
- 14 days ago - Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes - PRNewsWire
- 26 days ago - PAVmed Inc. (PAVM) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 26 days ago - PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results - PRNewsWire
- 27 days ago - Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results - PRNewsWire
- 5 weeks ago - PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025 - PRNewsWire
- 5 weeks ago - Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - PRNewsWire
- 6 weeks ago - NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD - PRNewsWire